aegyptin (NIAID)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameaegyptin (NIAID)
Drug Alias Namecollagen-platelet aggregation inhibitor (NIAID)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCollagen inhibitorsCoagulation factor VIII inhibitorsPlatelet membrane glycoprotein VI inhibitors +[4] 
TargetsCollagenCoagulation factor VIIIIntegrin alpha2/beta1 +[4] 
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A